Effects of Sandostatin on Blood Flow in Liver Tumors
Author Information
Author(s): D.M. Hemingway, S.A. Jenkins, T.G. Cooke
Primary Institution: University Departments of Surgery, Glasgow Royal Infirmary and Royal Liverpool Hospital, UK
Hypothesis
Manipulation of hepatic blood flow may improve drug delivery to hepatic tumors.
Conclusion
Infusion of SMS 201-995 significantly decreased hepatic arterial flow while increasing the tumor:liver blood flow ratio.
Supporting Evidence
- Infusion of SMS 201-995 resulted in a significant decrease in hepatic arterial flow.
- The tumor:liver blood flow ratio was significantly increased after SMS infusion.
- Blood flow to normal hepatic parenchyma was significantly reduced.
Takeaway
This study found that a drug called Sandostatin can change how blood flows in the liver, which might help deliver medicine better to liver tumors.
Methodology
Hepatic tumor was induced in rats, and blood flow was measured using a dual microsphere technique before and after SMS 201-995 infusion.
Limitations
The study was conducted in an experimental model, which may not fully represent human conditions.
Participant Demographics
Male Hooded Lister rats, weighing approximately 250g.
Statistical Information
P-Value
0.025
Statistical Significance
p=0.025
Want to read the original?
Access the complete publication on the publisher's website